(Q33542544)

English

Managing antipsychotic-induced tardive dyskinesia

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1 reference

Europe PubMed Central

Managing antipsychotic-induced tardive dyskinesia (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1 reference

based on heuristic

inferred from title

author name string

G Gardos

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

publication date

1 February 1999

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

187-193

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10082074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/10082074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ten-year outcome of tardive dyskinesia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10082074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prevalence of tardive dyskinesia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10082074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological treatments of tardive dyskinesia in the 1980s

1 reference

https://pubmed.ncbi.nlm.nih.gov/10082074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine dose in the United States and Europe: implications for therapeutic and adverse effects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10082074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine: neuroleptic-induced EPS and tardive dyskinesia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10082074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An open-label study of botulinum toxin A for treatment of tardive dystonia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10082074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Integrating incidence and prevalence of tardive dyskinesia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10082074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine, and clozapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/10082074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 5-year prospective longitudinal study of tardive dyskinesia: factors predicting appearance of new cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/10082074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Research Diagnoses for Tardive Dyskinesia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10082074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of clozapine on tardive dyskinesia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10082074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The evaluation and treatment of neuroleptic-induced movement disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/10082074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroleptic Treatment in Tardive Dyskinesia: Can It Be Developed Into a Clinical Strategy for Long-Term Treatment?1

1 reference

https://pubmed.ncbi.nlm.nih.gov/10082074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of TaqI A polymorphism of dopamine D2 receptor gene and tardive dyskinesia in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10082074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00002018-199920020-00007

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33542544&oldid=2195470416"